There were 1,106 press releases posted in the last 24 hours and 400,826 in the last 365 days.

IMPORTANT NANTHEALTH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against NantHealth, Inc. in the Central District of California

Lead Plaintiff Deadline is May 8, 2017

NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP   announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of purchasers of NantHealth, Inc. securities (NASDAQ:NH) (“NantHealth” or the “Company”): (1) pursuant or traceable to NantHealth’s initial public offering on or about June 1, 2016; and/or (2) from June 1, 2016 through March 6, 2017, inclusive (the “Class Period”).

Investors who have incurred losses in the shares of NantHealth, Inc. are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.

If   you have purchased shares of NantHealth, Inc  and would like to assist with the litigation process, you may, no later than May 8, 2017, request that the Court appoint you lead plaintiff of the proposed class.

The filed complaint alleges that defendants during the Class Period made false and misleading statements and/or failed to disclose that: (1) NantHealth founder Patrick Soon-Shiong donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; (2) as such, Nanthealth and Soon-Shiong violated federal tax laws—exposing Nanthealth to possible civil and criminal liability; (3) Nanthealth improperly recorded orders received from the University of Utah as GPS Cancer test orders; (4) in turn, Nanthealth reported false and inflated GPS Cancer order figures for the third quarter of 2016; and (5) as a result, defendants’ statements regarding NantHealth’s outlook and expected financial performance were false and misleading and lack a reasonable basis when made.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Follow the firm and learn about newly filed cases on Twitter and Facebook

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP 
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

Primary Logo